An Introduction To Can-Fite Ahead Of Phase II Psoriasis Data Next Week (CANF)

An Introduction To Can-Fite Ahead Of Phase II Psoriasis Data Next Week (CANF)

Can-Fite BioPharma Ltd. (CANF) is a clinical-stage biopharmaceutical company developing small molecule therapeutics for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. The lead compound, CF101, is in a Phase 2/3 …

13
Like
Save

Comments

Write a comment